PLEKHA4 and cancer: GO and KEGG enrichment results suggested that PLEKHA4 participated in various activities, including B cell-mediated immunity, immune effector process regulation, lymphocyte-facilitated immunity, lymphocyte activation regulation, Th1 and Th2 cell differentiation, the B cell receptor signaling pathway, and PD-L1 expression PD-1 checkpoint pathway in cancer.